Michael G. Mullen

Biography

Michael Mullen brings to Stonehill’s Meehan School of Business more than 30 years of international investment research, corporate finance and advisory, portfolio management and venture capital investment experience with a particular focus in life sciences and medical technology.  As a former partner of Wall Street-based Cowen & Co., he was a senior member of the #1 ranked investment research team in Medical Technology according to Greenwich Associates during most of the 1990’s.  He later joined the Bellevue Group of Zurich, Switzerland as a senior portfolio manager with responsibilities for its flagship funds BB Medtech and BB Biotech where he also led the research operation in its Boston office.  He is currently the Managing Director of Tarvos Capital Management, LLC, a consulting firm that maintained an exclusive investment research advisory relationship with Adamant Biomedical Investments AG.  In 2014, Adamant was acquired by the Bellevue Group where that advisory relationship continues.


In addition to his accomplished work experience, Mullen has previously taught financial and managerial accounting at the Kelly School of Business at Indiana University (IU) and has over the years, guest lectured at the IU MBA program among other colleges on topics such as equity research, portfolio management strategy, venture investing and entrepreneurship.  In addition to his teaching responsibilities, he is the founding director of the Stonehill College Investment Finance Initiative (SCIFI), faculty advisor for both Beta Alpha Psi and the Stonehill Financial Management Association and chair of the department’s Mission Strategy Committee.


Mullen is a Chartered Financial Analyst and a Chartered Alternative Investment Analyst.  He is a member of the CFA Society of Boston, the CAIA Chapter of Boston and member of the Board of Advisors of the IU MBA Investment Management Academy.  Previous Board of Director experiences include Centelion S.A.S. (Sanofi), Eyetech Pharmaceuticals, Theravance, Auxilium and formerly founding Chairman of EyeGate Pharmaceuticals of Waltham, MA.

Education

  • M.B A., Indiana University
  • B.S., Fordham University
  • Chartered Financial Analyst
  • Chartered Alternative Investment Analyst

Courses Taught

  • Corporate Finance
  • Advanced Corporate Finance and Modeling
  • Seminar in Financial Management
  • Investments
  • Applied Research & Portfolio Management
  • Entrepreneurial Finance